Day One Biopharmaceuticals Long Term Deferred Charges (Quarterly) Analysis

Day One Biopharmaceuticals, Inc. (DAWN)

9.25 -0.36 (-3.75%) USD | NASDAQ | Jan 08, 16:00

9.25 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for DAWN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Mersana Therapeutics, Inc.	--
Perspective Therapeutics, Inc.	--
Electromed, Inc.	--
InfuSystem Holdings, Inc.	--
Xtant Medical Holdings, Inc.	--